89 related articles for article (PubMed ID: 3023407)
1. Viral therapy: prospects for protease inhibitors.
Korant BD; Towatari T; Ivanoff L; Petteway S; Brzin J; Lenarcic B; Turk V
J Cell Biochem; 1986; 32(2):91-5. PubMed ID: 3023407
[TBL] [Abstract][Full Text] [Related]
2. Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells.
Korant BD; Brzin J; Turk V
Biochem Biophys Res Commun; 1985 Mar; 127(3):1072-6. PubMed ID: 2985055
[TBL] [Abstract][Full Text] [Related]
3. Production of species-unspecific antiviral inhibitors in cell-cultures and in chicken embryos under the influence of pyrazolon derivatives.
Saratikov AS; Yavorowskaya VE; Lutzeva MA; Prishchep TP; Blagerman SK; Kiseleva VN
Arzneimittelforschung; 1975 Jun; 25(6):878-9. PubMed ID: 169855
[No Abstract] [Full Text] [Related]
4. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells.
Korutla L; Kumar R
Biochem Biophys Res Commun; 1996 Mar; 220(3):670-4. PubMed ID: 8607823
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RNA virus replication in vitro by 3-deazacytidine and 3-deazauridine.
Khare GP; Sidwell RW; Huffman JH; Tolman RL; Robins RK
Proc Soc Exp Biol Med; 1972 Jul; 140(3):880-4. PubMed ID: 4339065
[No Abstract] [Full Text] [Related]
6. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells.
Romanutti C; Castilla V; Coto CE; Wachsman MB
Int J Antimicrob Agents; 2007 Mar; 29(3):311-6. PubMed ID: 17275263
[TBL] [Abstract][Full Text] [Related]
7. Viral proteinases--possible targets of antiviral drugs.
Maliar T; Baláz S; Tandlich R; Sturdík E
Acta Virol; 2002; 46(3):131-40. PubMed ID: 12580374
[TBL] [Abstract][Full Text] [Related]
8. Interactions between a viral protease and cystatins.
Korant B; Towatari T; Kelley M; Brzin J; Lenarcic B; Turk V
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():281-6. PubMed ID: 3060140
[TBL] [Abstract][Full Text] [Related]
9. Antiviral agents. 5H-as-Triazino(5,6-b) indoles.
Gladych JM; Hornby R; Hunt JH; Jack D; Boyle JJ; Ferlauto RJ; Haff RF; Kormendy CG; Stanfield FJ; Stewart RC
J Med Chem; 1972 Mar; 15(3):277-81. PubMed ID: 4333824
[No Abstract] [Full Text] [Related]
10. Study of antivirus activity of mineral condensed polyanions. II. Effect on vesicular stomatitis virus.
Raybaud N; Jasmin C; Huppert J; Chermann JC; Mathé G; Raynaud M
Rev Eur Etud Clin Biol; 1972 Mar; 17(3):295-9. PubMed ID: 4340879
[No Abstract] [Full Text] [Related]
11. In vitro effects of silicotungstate on some RNA viruses.
Jasmin C; Raybaud N; Chermann JC; Haapala D; Sinoussi F; Loustau CB; Bonissol C; Kona P; Raynaud M
Biomedicine; 1973 Jul; 18(4):319-27. PubMed ID: 4139979
[No Abstract] [Full Text] [Related]
12. Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic.
Thomson JA; Perni RB
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):606-17. PubMed ID: 17002221
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibitors of hepatitis C virus replication.
Neyts J
Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
[TBL] [Abstract][Full Text] [Related]
14. Proteinase inhibitors from Streptomyces with antiviral activity.
Serkedjieva J; Angelova L; Remichkova M; Ivanova I
J Basic Microbiol; 2006; 46(6):504-12. PubMed ID: 17139614
[TBL] [Abstract][Full Text] [Related]
15. Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors.
Ortqvist P; Peterson SD; Kerblom E; Gossas T; Sabnis YA; Fransson R; Lindeberg G; Helena Danielson U; Karlén A; Sandström A
Bioorg Med Chem; 2007 Feb; 15(3):1448-74. PubMed ID: 17113777
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of some South American medicinal plants.
Abad MJ; Bermejo P; Sanchez Palomino S; Chiriboga X; Carrasco L
Phytother Res; 1999 Mar; 13(2):142-6. PubMed ID: 10190189
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis C virus RNA replicons by peptide aptamers.
Trahtenherts A; Gal-Tanamy M; Zemel R; Bachmatov L; Loewenstein S; Tur-Kaspa R; Benhar I
Antiviral Res; 2008 Mar; 77(3):195-205. PubMed ID: 18243349
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of constituents of Tamus communis.
Aquino R; Conti C; De Simone F; Orsi N; Pizza C; Stein ML
J Chemother; 1991 Oct; 3(5):305-9. PubMed ID: 1667189
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
Fredericksen BL; Whitt MA
Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
